Duggan Robert W's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Dec 6, 2023
- Accession no.
- 0001437749-23-033803
- Filed
- Dec 6, 2023
- Trade date
- Dec 4, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $280.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Duggan Robert WCIK 0001055919 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | Common Stock | MOption exerciseAcquired | +20,000 | $10.66 | +$213,200 | 36,571,461 | Direct | |
| Dec 4, 2023 | Common Stock | MOption exerciseAcquired | +20,347 | $10.66 | +$216,899.02 | 36,591,808 | Direct | |
| Dec 4, 2023 | Common Stock | PPurchaseAcquired | +27,000 | $10.38 | +$280,260 | 285,544 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct | |
| Dec 4, 2023 | Common Stock | MOption exerciseDisposed | −20,347 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.